Predictive MGMT Status in a Homogeneous Cohort of IDH Wildtype Glioblastoma Patients

Acta neuropathologica communications - United Kingdom
doi 10.1186/s40478-019-0745-z
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

The Predictive but Not Prognostic Value of MGMT Promoter Methylation Status in Elderly Glioblastoma Patients: A Meta-Analysis

PLoS ONE
Multidisciplinary
2014English

Prognostic Significance of IDH-1 and MGMT in Patients With Glioblastoma: One Step Forward, and One Step Back?

Radiation Oncology
Nuclear MedicineRadiologyImagingOncology
2011English

Personalized Treatment Strategies in Glioblastoma: MGMT Promoter Methylation Status

OncoTargets and Therapy
OncologyPharmacology
2013English

MGMT Methylation Status: The Advent of Stratified Therapy in Glioblastoma?

Disease Markers
BiochemistryMedicineClinical BiochemistryMolecular BiologyGenetics
2007English

cIMPACT-NOW Update 3: Recommended Diagnostic Criteria for “Diffuse Astrocytic Glioma, IDH-wildtype, With Molecular Features of Glioblastoma, WHO Grade IV”

Acta Neuropathologica
Forensic MedicineMolecular NeurosciencePathologyNeurologyCellular
2018English

A Novel Analytical Model of MGMT Methylation Pyrosequencing Offers Improved Predictive Performance in Patients With Gliomas

Modern Pathology
Forensic MedicinePathology
2018English

Prognostic Value of MGMT Promoter Methylation in Glioblastoma Patients Treated With Temozolomide-Based Chemoradiation: A Portuguese Multicentre Study

Oncology Reports
MedicineCancer ResearchOncology
2010English

A Novel Enhancer Regulates MGMT Expression and Promotes Temozolomide Resistance in Glioblastoma

Nature Communications
AstronomyGeneticsMolecular BiologyBiochemistryChemistryPhysics
2018English

Clinical Neuropathology Practice Guide 06-2012: MGMT Testing in Elderly Glioblastoma Patients – Yes, but How?

Clinical Neuropathology
MedicineForensic MedicinePathologyNeurology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy